Skip to main content
OpenTrials
Completed

NCT Number: NCT03237208

Transcutaneous Electrical Nerve Stimulation Treatment of Renal Colic

The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Adiyaman University Research Hospital

Adıyaman, Central, 02000, Turkey (Türkiye)

About this study

Renal colic, an intensely painful condition, is a common presenting complaint to the emergency department. Parenteral opioids, nonsteroidal anti-inflammatory drugs and acetaminophen are commonly used to provide relief from renal colic. The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department.

Study Design and Setting: A prospective, randomized, double-blind, placebo controlled, single-center, clinical trial will be conducted in emergency department of a tertiary care university hospital.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients with renal colic admitted to emergency department.
  • Adult patients who were definitively diagnosed with acute renal colic due to urinary system stones using unenhanced computed abdominopelvic tomography

Exclusion criteria

  • Patients below 18 years of age
  • Patients with haemodynamic instability, with fever (temperature=38°C [100.4°F]), with evidence of peritoneal inflammation,
  • Patients using any analgesic within the previous 48 hours of emergency department presentation
  • Patients who declined to participate

Treatment and study plan

TENS

Device

Transcutaneous electrical nerve stimulation (TENS) treatment will be activated.

Placebo Group

Device

Transcutaneous electrical nerve stimulation treatment will not be activated.

Primary outcomes

  1. Reduction of the intensity of pain

    Time frame: 0 minutes, 15 minutes and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

    Subjects will complete 100 mm visual analog scales at time zero, 15 and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Secondary outcomes

  1. Adverse events

    Time frame: 30 minutes after

    30 minutes after taking Transcutaneous Electrical Nerve Stimulation application

Sponsors and collaborators

Lead sponsor

Adiyaman University Research Hospital

Other

Registry information

Official study title

Patients Undergoing Routine Transcutaneous Electrical Nerve Stimulation Treatment in Patients With Renal Colic Who Admitted to the Emergency Department: A Randomized Double Blind Placebo-controlled Trial

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Aug 2, 2017
Registry last updated
Sep 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.